Manulife (Manufacturers Life Insurance)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.53M Buy
16,300
+248
+2% +$118K 0.01% 933
2025
Q4
$9.36M Sell
16,052
-1,275
-7% -$651K 0.01% 904
2025
Q3
$7.95M Sell
17,327
-6,089
-26% -$2.27M 0.01% 983
2025
Q2
$7.09M Buy
23,416
+471
+2% +$140K 0.01% 1005
2025
Q1
$7.6M Sell
22,945
-1,135
-5% -$373K 0.01% 968
2024
Q4
$7.43M Sell
24,080
-5,877
-20% -$1.65M 0.01% 1033
2024
Q3
$6.36M Sell
29,957
-5,721
-16% -$1.46M 0.01% 1107
2024
Q2
$10M Buy
35,678
+4,937
+16% +$1.18M 0.01% 841
2024
Q1
$8.21M Buy
30,741
+14,662
+91% +$3.45M 0.01% 953
2023
Q4
$3.72M Buy
16,079
+2,219
+16% +$388K ﹤0.01% 1272
2023
Q3
$2.02M Buy
13,860
+8,164
+143% +$1.54M ﹤0.01% 1431
2023
Q2
$1.32M Buy
5,696
+406
+8% +$110K ﹤0.01% 1539
2023
Q1
$1.28M Buy
5,290
+304
+6% +$82.8K ﹤0.01% 1523
2022
Q4
$1.45M Sell
4,986
-106
-2% -$10.4K ﹤0.01% 1475
2022
Q3
$331K Sell
5,092
-102
-2% -$7.09K ﹤0.01% 2243
2022
Q2
$372K Buy
5,194
+214
+4% +$15.7K ﹤0.01% 2239
2022
Q1
$489K Sell
4,980
-1,203
-19% -$101K ﹤0.01% 2218
2021
Q4
$524 Buy
6,183
+56
+0.9% +$4.6K ﹤0.01% 2228
2021
Q3
$489K Sell
6,127
-460
-7% -$39.7K ﹤0.01% 2305
2021
Q2
$642K Buy
6,587
+1,450
+28% +$172K ﹤0.01% 2256
2021
Q1
$601K Sell
5,137
-270
-5% -$31.5K ﹤0.01% 2176
2020
Q4
$601K Buy
5,407
+131
+2% +$16K ﹤0.01% 2091
2020
Q3
$626K Sell
5,276
-93
-2% -$10.1K ﹤0.01% 1878
2020
Q2
$552K Sell
5,369
-250
-4% -$24.6K ﹤0.01% 1911
2020
Q1
$375K Buy
5,619
+712
+15% +$59.3K ﹤0.01% 1969
2019
Q4
$447K Sell
4,907
-191
-4% -$18.5K ﹤0.01% 2116
2019
Q3
$434K Hold
5,098
﹤0.01% 2108
2019
Q2
$534K Buy
5,098
+403
+9% +$43.2K ﹤0.01% 2011
2019
Q1
$588K Buy
4,695
+460
+11% +$57.2K ﹤0.01% 1996
2018
Q4
$477K Sell
4,235
-416
-9% -$64.4K ﹤0.01% 1987
2018
Q3
$996K Buy
4,651
+135
+3% +$33.9K ﹤0.01% 1801
2018
Q2
$1.26M Buy
4,516
+751
+20% +$132K ﹤0.01% 1734
2018
Q1
$439K Buy
3,765
+212
+6% +$26.2K ﹤0.01% 2428
2017
Q4
$326K Buy
3,553
+1,399
+65% +$79.9K ﹤0.01% 2627
2017
Q3
$96K Buy
2,154
+2,091
+3,319% +$39.1K ﹤0.01% 3335
2017
Q2
$1K Buy
63
+34
+117% +$531 ﹤0.01% 4224
2017
Q1
$0 Hold
29
﹤0.01% 4299
2016
Q4
$0 Hold
29
﹤0.01% 4408
2016
Q3
$0 Hold
29
﹤0.01% 4327
2016
Q2
$0 Sell
29
-453
-94% -$5.43K ﹤0.01% 4302
2016
Q1
$4K Sell
482
-1,338
-74% -$11.2K ﹤0.01% 3837
2015
Q4
$22 Hold
1,820
﹤0.01% 3412
2015
Q3
$111 Buy
1,820
+77
+4% +$5.56K ﹤0.01% 3076
2015
Q2
$136 Buy
1,743
+257
+17% +$21.6K ﹤0.01% 3175
2015
Q1
$101 Buy
1,486
+64
+5% +$5.49K ﹤0.01% 3163
2014
Q4
$132 Buy
1,422
+95
+7% +$9.82K ﹤0.01% 2933
2014
Q3
$140 Buy
1,327
+174
+15% +$24.2K ﹤0.01% 2879
2014
Q2
$165K Buy
1,153
+17
+1% +$2.48K ﹤0.01% 2869
2014
Q1
$172 Buy
1,136
+210
+23% +$41.4K ﹤0.01% 2819
2013
Q4
$169 Sell
926
-42
-4% -$7.69K ﹤0.01% 2820
2013
Q3
$214 Sell
968
-27
-3% -$5.74K ﹤0.01% 2608
2013
Q2
$174K Buy
+995
New +$259K ﹤0.01% 2680

Other funds holding MDGL

Manulife (Manufacturers Life Insurance)'s MDGL Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Madrigal Pharmaceuticals (MDGL) stake by 1.5% in Q1 2026, buying an estimated $118K and bringing the position to 16,300 shares worth $8.53M. The position accounts for 0.01% of the portfolio, ranked #933.

Manulife (Manufacturers Life Insurance) first reported a position in MDGL in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q2 2024. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 16,300 shares of Madrigal Pharmaceuticals worth $8.53M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 248 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $118K.
  • Madrigal Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #933 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Madrigal Pharmaceuticals position peaked at $10M in Q2 2024.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.